Effectiveness of the HuCare Quality Improvement Strategy on health-related quality of life in patients with cancer: study protocol of a stepped-wedge cluster randomised controlled trial (HuCare2 study)
Open Access
Abstract
Introduction Our group previously demonstrated the feasibility of the HuCare Quality Improvement Strategy (HQIS), aimed at integrating into practice six psychosocial interventions recommended by international guidelines. This trial will assess whether the introduction of the strategy in oncology wards improves patient’s health-related quality of life (HRQoL). Methods and analysis Multicentre, incomplete stepped-wedge cluster randomised controlled trial, conducted in three clusters of five centres each, in three equally spaced time epochs. The study also includes an initial epoch when none of the centres are exposed to the intervention, and a final epoch when all centres will have implemented the strategy. The intervention is applied at a cluster level, and assessed at an individual level with cross-sectional model. A total of 720 patients who received a cancer diagnosis in the previous 2 months and about to start medical treatment will be enrolled. The primary aim is to evaluate the effectiveness of the HQIS versus standard care in terms of improvement of at least one of two domains (emotional and social functions) of HRQoL using the EORTC QLQ-C30 (European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 items) questionnaire, at baseline and at 3 months. This outcome was chosen because patients with cancer generally exhibit low HRQoL, particularly at certain stages of care, and because it allows to assess the strategy’s impact as perceived by patients themselves. The HQIS comprises three phases: (1) clinician training—to improve communication-relational skills and instruct on the project; (2) centre support—four on-site visits by experts of the project team, aimed to boost motivation, help with context analysis and identification of solutions; (3) implementation of Evidence-Based Medicine (EBM) recommendations at the centre. Ethics and dissemination Ethics committee review approval has been obtained from the Ethics Committee of Parma. Results will be disseminated at conferences, and in peer-reviewed and professional journals intended for policymakers and managers. Trial registration number NCT03008993; Pre-results.Keywords
Funding Information
- Associazione di volontariato medicina e arte onlus - MEDeA
- Associazione Italiana di Oncologia Medica
This publication has 80 references indexed in Scilit:
- Trends in the 15D health-related quality of life over the first year following diagnosis of head and neck cancerEuropean Archives of Oto-Rhino-Laryngology, 2015
- Patient-reported outcome assessment after total joint replacement: comparison of questionnaire completion times on paper and tablet computerArchives of orthopaedic and trauma surgery, 2015
- How much do cancer‐related symptoms contribute to health‐related quality of life in lung and colorectal cancer patients? A report from the Cancer Care Outcomes Research and Surveillance (CanCORS) ConsortiumCancer, 2015
- The changing landscape of cancer care - the impact of psychosocial clinical practice guidelinesPsycho-Oncology, 2015
- Stepped‐wedge cluster randomised controlled trials: a generic framework including parallel and multiple‐level designsStatistics in Medicine, 2014
- Changes in Insurance Physicians’ Attitudes, Self-Efficacy, Intention, and Knowledge and Skills Regarding the Guidelines for Depression, Following an Implementation StrategyJournal of Occupational Rehabilitation, 2012
- A New Quality Standard: The Integration of Psychosocial Care Into Routine Cancer CareJournal of Clinical Oncology, 2012
- Quality-of-Life assessment for routine oncology clinical practice.2008
- Enduring impact of communication skills training: results of a 12-month follow-upBritish Journal of Cancer, 2003
- Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology.Journal of Clinical Oncology, 1996